October 1, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Higher product sales help Amgen beat analyst expectations for first quarter

IN THIS ARTICLE

Amgen's first quarter revenues and earnings per share beat analyst expectations, reaching $5.6 billion and $3.25 respectively on higher product sales, the company reported April 24. In particular, the Thousand Oaks biotech giant’s cholesterol drug Repatha saw a 151 percent increase in sales after receiving U.S. Food and Drug Administration approval in December to be…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.